Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AMLXAMLX
Showing 8 of 16 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AMYLYX PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 2.9M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $51.3M as of 2026-Q2. The position was increased (+8.8% shares). AMLX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$51.3M

Current Shares

2.9M

Total Value Change

+$46.1M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.9M
+8.8%
$51.3M0.0%$17.96
32
2026-Q1
Increased
2.6M
+0.5%
$36.5M0.0%$14.11
29
2025-Q4
Increased
2.6M
+30.0%
$31.6M0.0%$12.00
36
2025-Q3
Increased
2M
+54.9%
$27.3M0.0%$14.90
40
2025-Q2
Decreased
1.3M
-35.2%
$8.3M0.0%$6.33
0
2025-Q1
Increased
2M
+7.7%
$7.1M0.0%$3.66
29
2024-Q4
Increased
1.9M
+15.2%
$7M0.0%$3.84
31
2024-Q3
Decreased
1.6M
-38.2%
$5.2M0.0%$3.08
0

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used